Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Chemmedchem
|
December 30, 2017
Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death
Manuela Basso, Huan Huan Chen, Debasmita Tripathy, et al.
Chemmedchem
|
March 5, 2011
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity
Sergio Valente, Maria Tardugno, Mariarosaria Conte, et al.
European Journal of Heart Failure
|
January 14, 2025
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysis
Rosaria Benedetti, Ugo Chianese, Chiara Papulino, et al.
Journal of Medicinal Chemistry
|
October 4, 2012
Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities
Raquel Pereira, Rosaria Benedetti, Santiago Pérez-Rodríguez, et al.
Scientific Reports
|
September 17, 2017
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses
Angela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 12, 2022
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca, Tania Moccia, Federica Iannelli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 4, 2022
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca, Tania Moccia, Federica Iannelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Molecular Cancer
|
June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
Nunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Chemmedchem
|
December 30, 2017
Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death
Manuela Basso, Huan Huan Chen, Debasmita Tripathy, et al.
Chemmedchem
|
March 5, 2011
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity
Sergio Valente, Maria Tardugno, Mariarosaria Conte, et al.
European Journal of Heart Failure
|
January 14, 2025
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysis
Rosaria Benedetti, Ugo Chianese, Chiara Papulino, et al.
Journal of Medicinal Chemistry
|
October 4, 2012
Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities
Raquel Pereira, Rosaria Benedetti, Santiago Pérez-Rodríguez, et al.
Scientific Reports
|
September 17, 2017
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses
Angela Nebbioso, Rosaria Benedetti, Mariarosaria Conte, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 12, 2022
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca, Tania Moccia, Federica Iannelli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 4, 2022
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca, Tania Moccia, Federica Iannelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer
Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Molecular Cancer
|
June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
Nunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Page
of 7